Y Pereon
Overview
Explore the profile of Y Pereon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vicart S, Pereon Y, Ghorab K, Pegat A, Dufresne R, Zozulya-Weidenfeller A, et al.
Rev Neurol (Paris)
. 2024 May;
180(8):791-797.
PMID: 38811249
Non-dystrophic myotonias (NDM) are disabling genetic diseases that impact quality of life. To reduce the impact of NDM, patients develop coping strategies such as lifestyle adaptation and avoiding key triggers....
2.
Adams D, Cintas P, Sole G, Tard C, Labeyrie C, Echaniz-Laguna A, et al.
Rev Neurol (Paris)
. 2024 Apr;
180(7):661-672.
PMID: 38643028
Objective: We aimed to describe characteristics of patients with ATTR variant polyneuropathy (ATTRv-PN) and ATTRv-mixed and assess the real-world use and safety profile of tafamidis meglumine 20mg. Methods: Thirty-eight French...
3.
Drouin E, Magot A, Pereon Y
Rev Neurol (Paris)
. 2023 Jul;
179(8):866-871.
PMID: 37460333
No abstract available.
4.
Cintas P, Bouhour F, Cauquil C, Masingue M, Tard C, Sacconi S, et al.
Rev Neurol (Paris)
. 2023 Apr;
179(8):914-922.
PMID: 37019741
Treatment strategies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) must be adapted on a case-to-case basis. Validated and reproducible tools for monitoring treatment response are required at diagnosis, when initiating treatment...
5.
Barrois R, Barnerias C, Deladriere E, Leloup-Germa V, Tervil B, Audic F, et al.
Neuromuscul Disord
. 2023 Mar;
33(4):309-314.
PMID: 36881951
Spinal muscular atrophy 1 (SMA1) is a severe early genetic disease with degeneration of motor neurons. Motor development is still suboptimal after gene replacement therapy in symptomatic patients. In this...
6.
Pereon Y
Rev Neurol (Paris)
. 2022 Dec;
179(1-2):5-9.
PMID: 36529569
Inherited neuropathies are a genetically and phenotypically heterogenous group of disorders leading to sensory and motor dysfunction. For years, these neuropathies have been considered as non-treatable diseases, as no drug...
7.
Fargeot G, Gitiaux C, Magy L, Pereon Y, Delmont E, Viala K, et al.
Rev Neurol (Paris)
. 2022 Oct;
178(9):953-968.
PMID: 36182621
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune disorder of the peripheral nervous system, primarily affecting the myelin sheath. The pathophysiology of CIDP is complex, involving both humoral and...
8.
Balloy G, Magot A, Fayet G, Bonnemain B, Pereon Y
Rev Neurol (Paris)
. 2021 Dec;
178(1-2):157-158.
PMID: 34955227
No abstract available.
9.
Magot A, Mahe B, Balloy G, Chevallier P, Pereon Y
Rev Neurol (Paris)
. 2020 Oct;
177(4):435-436.
PMID: 33019998
No abstract available.
10.
Dos Santos A, Pereon Y, Wiertlewski S, Magot A
Eur J Neurol
. 2020 Aug;
27(12):e94.
PMID: 32748451
No abstract available.